Skip to content
HW191211 5th Annual PREDiCT 3D Oncology & Tissue Models Summit logo

September 2021

  • Home
  • About
    • About Event
    • About PREDiCT
    • Interactive Virtual Experience
    • Testimonials
    • Content Library
    • Digital FAQs
  • Program
    • 2020 Event Guide
    • 2020 Speaker Faculty
    • Agenda
      • 2020 Day One
      • 2020 Day Two
  • Partnerships
    • Partnership Opportunities
    • 2020 Partners
    • 2020 Media Partners
    • PREDiCT Series Prospectus
  • Get involved
    • Register
    • Contact us

Aracari Biosciences

By djessica | 11th June 2020

Aracari Biosciences’ propriety human Vascularized Micro-Organ (VMO) technology is the first to grow living, perfusable, human blood vessels within a microfluidic 3D platform. Growth of microtumors in these networks recapitulates the physiological delivery of nutrients, drug compounds, or immune cells through living blood vessels, providing a powerful tool for oncology and immune-oncology applications.  At Aracari we collaborate with pharmaceutical clients to more accurately and efficiently test drug compounds to de-risk costly preclinical and clinical failures.

www.aracaribio.com

OUR CONTACT DETAILS

E: info@hansonwade.com

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

LOCATION

This meeting ran digitally on September 30 – October 1.

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok